O slideshow foi denunciado.

Hepatocellular Carcinoma (HCC)

2

Compartilhar

Carregando em…3
×
1 de 11
1 de 11

Mais Conteúdo rRelacionado

Semelhante a Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC)

  1. 1. Hepatocellular Carcinoma (HCC) Market Insights, Epidemiology and Market Forecast- 2027
  2. 2. Hepatocellular carcinoma (HCC) is the most common type of liver cancer, and, also a leading cause of cancer-related death worldwide. Half of all cases of HCC are associated with hepatitis B virus infection, with a further 25% associated with hepatitis C virus. The disease is found to be more common in males as compared to females.04 03 02 01 DelveInsight © 2018 | All rights reserved The incidence and subsequent mortality of the disease is on a continuous upsurge despite gradually improving treatment. Hepatocellular Carcinoma (HCC)
  3. 3. DelveInsight © 2018 | All rights reserved Cases of (HCC) The total incident cases of HCC in the G8 countries i.e., the United States, EU-5 countries (Germany, France, Italy, Spain and the U.K.), Japan and China, were found to be 4,58,170 in 2016, while the corresponding diagnosed advanced HCC cases in the G8 countries were found to be 1, 60,565 for the same year.
  4. 4. The United States had the highest market share of HCC in 2016, as compared to the EU5 countries (Germany, France, Italy, Spain & UK) Japan and China. Among the EU5 countries, Italy accounted for the highest market size, while the UK had the lowest market in 2016. DelveInsight © 2018 | All rights reserved Market Outlook The analysis conducted for the period of 2016-2027, the market size of Hepatocellular Carcinoma is expected to reach USD 3.8 Billion in 2027 for the G8 countries.
  5. 5. TECENTRIQ WITH AVASTIN RAMUCIRUMAB CABOZANTINIB LENVIMA DelveInsight © 2018 | All rights reserved Emerging Therapies (Companies) (Drugs)
  6. 6. DelveInsight © 2018 | All rights reserved Report HCC Report Insights  Patient Population  Therapeutic Approaches  Pipeline Analysis  Market Size and Trends  Market Opportunities  Impact of upcoming Therapies HCC Report Key Strengths  10 Year Forecast  G8 Coverage  Epidemiology Segmentation  Drugs Uptake  Highly Analyzed Market  Key Cross Competition HCC Report Assessment  Current Treatment Practices  Unmet Needs  Detailed Pipeline Product Profiles  Market Attractiveness  Market Drivers and Barriers HCC Report Key Strengths HCC Report Insights HCC Report Assessment
  7. 7. DelveInsight © 2018 | All rights reserved Complete Information For complete information on Hepatocellular Carcinoma (HCC) Market Insights, Epidemiology and Market Forecast-2027 please click the link below CLICK HERE OR Write Us At info@delveinsight.com
  8. 8. About DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to- end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for improving their performances to stay ahead of the competitors. Mission To provide “insights across the value chain” and helping the organization to take a prudent business decision through the use and analysis of actionable market intelligence. The mission also is to provide the most effective result and efficient service with utmost client care for maintaining a long- term relationship with them. Vision To be the most trusted market research & business consulting firm in the world; and to continue enable the Pharma & Bio-Tech companies to achieve their goals with the best strategic insight and competitive solution. The vision also is inclusive of becoming a one-stop solution provider for the entire gamut of drug development process. 1 2 3 DelveInsight © 2018 | All rights reserved About DelveInsight
  9. 9. Opportunity Assessment5 Report Store6 Competitive Analysis7 Socialytics8 Forecasting 1 Pipeline 2 Consulting 3 Market Intelligence 4 DelveInsight © 2018 | All rights reserved Service Offerings by DelveInsight
  10. 10. DelveInsight © 2018 | All rights reserved Contact Us info@delveinsight.com +91-11-4568 9769 www.delveinsight.com blog/delveInsight/ twitter/delveInsight LinkedIn/delveInsight

×